These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 8205528)
61. Phase I evaluation of interleukin-2-transfected irradiated allogeneic melanoma for the treatment of metastatic melanoma: appendix 1: protocol. Das Gupta TK; Cohen EP; Richards JM Hum Gene Ther; 1997 Sep; 8(14):1701-14. PubMed ID: 9322873 [TBL] [Abstract][Full Text] [Related]
62. [Identification of tumor antigens: strategies and perspectives]. Jäger D; Zippelius A; Knuth A Praxis (Bern 1994); 2004 Sep; 93(39):1584-8. PubMed ID: 15500242 [TBL] [Abstract][Full Text] [Related]
63. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. van den Boorn JG; Picavet DI; van Swieten PF; van Veen HA; Konijnenberg D; van Veelen PA; van Capel T; Jong EC; Reits EA; Drijfhout JW; Bos JD; Melief CJ; Luiten RM J Invest Dermatol; 2011 Jun; 131(6):1240-51. PubMed ID: 21326294 [TBL] [Abstract][Full Text] [Related]
64. Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines. Van den Eynde B; Gaugler B; van der Bruggen P; Coulie P; Brichard V; Boon T Biochem Soc Trans; 1995 Aug; 23(3):681-6. PubMed ID: 8566443 [No Abstract] [Full Text] [Related]
65. The Antigenicity of the Tumor Cell - Context Matters. Kristensen VN N Engl J Med; 2017 Feb; 376(5):491-493. PubMed ID: 28146670 [No Abstract] [Full Text] [Related]
66. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Robbins PF; Lu YC; El-Gamil M; Li YF; Gross C; Gartner J; Lin JC; Teer JK; Cliften P; Tycksen E; Samuels Y; Rosenberg SA Nat Med; 2013 Jun; 19(6):747-52. PubMed ID: 23644516 [TBL] [Abstract][Full Text] [Related]
67. Evolving role of tumor antigens for future melanoma therapies. Andrews MC; Woods K; Cebon J; Behren A Future Oncol; 2014 Jun; 10(8):1457-68. PubMed ID: 25052755 [TBL] [Abstract][Full Text] [Related]
68. Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes. Carretero R; Wang E; Rodriguez AI; Reinboth J; Ascierto ML; Engle AM; Liu H; Camacho FM; Marincola FM; Garrido F; Cabrera T Int J Cancer; 2012 Jul; 131(2):387-95. PubMed ID: 21964766 [TBL] [Abstract][Full Text] [Related]
69. The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen identified in a patient with a dramatic response to immunotherapy. Khong HT; Rosenberg SA Cancer Res; 2002 Jun; 62(11):3020-3. PubMed ID: 12036907 [TBL] [Abstract][Full Text] [Related]
70. Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinity. Lucchese A; Willers J; Mittelman A; Kanduc D; Dummer R J Immunol; 2005 Nov; 175(10):7009-20. PubMed ID: 16272362 [TBL] [Abstract][Full Text] [Related]
71. In situ detection of antigen-specific tumor-infiltrating lymphocytes using newly designed tetramers. Bras-Gonçalves R; Le Gal FA; Avril MF; Dalod M; Connan F; Chaboissier A; Choppin J; Guillet JG J Immunol Methods; 2003 Sep; 280(1-2):103-11. PubMed ID: 12972191 [TBL] [Abstract][Full Text] [Related]